The effects CCL2 are multiple and include regulation of myeloid cell function, immune response, modulation of cell-killing properties of monocytes and macrophages, but also linking obesity to its related cardio-metabolic and malignant diseases. This evidence concerns the gene CCL2 and obesity due to melanocortin 4 receptor deficiency.